The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease
Abstract
Mutation-based molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD) is complicated by genetic and allelic heterogeneity, large multi-exon genes, duplication of PKD1, and a high level of unclassified variants (UCV). Present mutation detection levels are 60 to 70%, and PKD1 and PKD2 UCV have not been systematically classified. This study analyzed the uniquely characterized Consortium for Radiologic Imaging Study of PKD (CRISP) ADPKD population by molecular analysis. A cohort of 202 probands was screened by denaturing HPLC, followed by direct sequencing using a clinical test of 121 with no definite mutation (plus controls). A subset was also screened for larger deletions, and reverse transcription-PCR was used to test abnormal splicing. Definite mutations were identified in 127 (62.9%) probands, and all UCV were assessed for their potential pathogenicity. The Grantham Matrix Score was used to score the significance of the substitution and the conservation of the residue in orthologs and defined domains. The likelihood for aberrant splicing and contextual information about the UCV within the patient (including segregation analysis) was used in combination to define a variant score. From this analysis, 44 missense plus two atypical splicing and seven small in-frame changes were defined as probably pathogenic and assigned to a mutation group. Mutations were thus defined in 180 (89.1%) probands: 153 (85.0%) PKD1 and 27 (15.0%) PKD2. The majority were unique to a single family, but recurrent mutations accounted for 30.0% of the total. A total of 190 polymorphic variants were identified in PKD1 (average of 10.1 per patient) and eight in PKD2. Although nondefinite mutation data must be treated with care in the clinical setting, this study shows the potential for molecular diagnostics in ADPKD that is likely to become increasingly important as therapies become available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Amino Acid Difference Formula to Help Explain Protein Evolution
Grantham, R. (1974) · Science · doi:10.1126/science.185.4154.862 · Cited by 2,363
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057
ESEfinder: a web resource to identify exonic splicing enhancers
Cartegni, L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg616 · Cited by 1,603
Improved splice site detection in Genie
Reese, M. G., Eeckman, F. H., Kulp, D., & Haussler, D. (1997) · Proceedings of the first annual international conference on Computational molecular biology - RECOMB '97 · doi:10.1145/267521.267766 · Cited by 1,439
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406
Predicting the Effects of Amino Acid Substitutions on Protein Function
Ng, P. C., & Henikoff, S. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115630 · Cited by 978
Yoder, B. K., Hou, X., & Guay-Woodford, L. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000029587.47950.25 · Cited by 935
Self-citationHughes, J., Ward, C. J., Peral, B., Aspinwall, R., Clark, K., San Millán, J. L., Gamble, V., & Harris, P. C. (1995) · Nature Genetics · doi:10.1038/ng0695-151 · Cited by 910
Self-citationDise, T. E. P. K. (1994) · Cell · doi:10.1016/0092-8674(94)90137-6 · Cited by 903
Volume Progression in Polycystic Kidney Disease
Grantham, J. J., Torres, V. E., Chapman, A. B., Guay-Woodford, L. M., Bae, K. T., King, B. F., Wetzel, L. H., Baumgarten, D. A., Kenney, P. J., Harris, P. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054341 · Cited by 807
Self-citationPolycystin-2 is an intracellular calcium release channel
Koulen, P., Cai, Y., Geng, L., Maeda, Y., Nishimura, S., Witzgall, R., Ehrlich, B. E., & Somlo, S. (2002) · Nature Cell Biology · doi:10.1038/ncb754 · Cited by 706
Tavtigian, S. V., Deffenbaugh, A. M., Yin, L., Judkins, T., Scholl, T., Samollow, P. B., de Silva, D., Zharkikh, A., & Thomas, A. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033878 · Cited by 669
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Hateboer, N., v Dijk, M. A., Bogdanova, N., Coto, E., Saggar-Malik, A. K., Millan, J. L. S., Torra, R., Breuning, M., & Ravine, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03495-3 · Cited by 628
Polycystic kidney disease: The complete structure of the PKD1 gene and its protein
The International Polycystic Kidney Disease Consortium (1995) · Cell · doi:10.1016/0092-8674(95)90339-9 · Cited by 625
Ravine, D., Sheffield, L., Danks, D. M., Gibson, R. N., Walker, R. G., & Kincaid-Smith, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92026-5 · Cited by 564
Pazour, G. J., San Agustin, J. T., Follit, J. A., Rosenbaum, J. L., & Witman, G. B. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00877-1 · Cited by 531
A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma
Winandy, S., Wu, P., & Georgopoulos, K. (1995) · Cell · doi:10.1016/0092-8674(95)90170-1 · Cited by 527
Chapman, A. B., Guay-Woodford, L. M., Grantham, J. J., Torres, V. E., Bae, K. T., Baumgarten, D. A., Kenney, P. J., King, B. F., Glockner, J. F., Wetzel, L. H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00185.x · Cited by 413
Self-citationCooper, D., & Krawczak, M. (1990) · Human Genetics · doi:10.1007/bf00276326 · Cited by 387
Identification and Characterization of Polycystin-2, thePKD2 Gene Product
Cai, Y., Maeda, Y., Cedzich, A., Torres, V. E., Wu, G., Hayashi, T., Mochizuki, T., Park, J. H., Witzgall, R., & Somlo, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28557 · Cited by 364
Self-citationMathe, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj518 · Cited by 340
Qian, F., Boletta, A., Bhunia, A. K., Xu, H., Liu, L., Ahrabi, A. K., Watnick, T. J., Zhou, F., & Germino, G. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252484899 · Cited by 329
Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases
Torres, V. E., & Harris, P. C. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0070 · Cited by 296
Self-citationMLPA and MAPH: New techniques for detection of gene deletions
Sellner, L. N., & Taylor, G. R. (2004) · Human Mutation · doi:10.1002/humu.20035 · Cited by 291
Genetic Heterogeneity of Polycystic Kidney Disease in Europe1
Peters, D. J. M., & Sandkuijl, L. A. (2015) · Contributions to Nephrology · doi:10.1159/000421651 · Cited by 282
Evidence for a third genetic locus for autosomal dominant polycystic kidney disease
Daoust, M. C., Reynolds, D. M., Bichet, D. G., & Somlo, S. (1995) · Genomics · doi:10.1016/0888-7543(95)80020-m · Cited by 272
Harris, P. C., Bae, K. T., Rossetti, S., Torres, V. E., Grantham, J. J., Chapman, A. B., Guay-Woodford, L. M., King, B. F., Wetzel, L. H., Baumgarten, D. A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080835 · Cited by 271
Self-citationMoy, G. W., Mendoza, L. M., Schulz, J. R., Swanson, W. J., Glabe, C. G., & Vacquier, V. D. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.4.809 · Cited by 242
Molecular pathogenesis of ADPKD: The polycystin complex gets complex
Ong, A. C. M., & Harris, P. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00201.x · Cited by 242
Self-citationMutation Analysis of the Entire PKD1 Gene: Genetic and Diagnostic Implications
Rossetti, S., Strmecki, L., Gamble, V., Burton, S., Sneddon, V., Peral, B., Roy, S., Bakkaloglu, A., Komel, R., Winearls, C. G., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316939 · Cited by 232
Self-citationParnell, S. C., Magenheimer, B. S., Maser, R. L., Rankin, C. A., Smine, A., Okamoto, T., & Calvet, J. P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9514 · Cited by 227
The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease
Bycroft, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.297 · Cited by 219
The nature and mechanisms of human gene mutation
Cooper, D. N., Krawczak, M., & Antonarakis, S. E. (1998) · McGraw-Hill eBooks · doi:10.1036/ommbid.20 · Cited by 199
A complete mutation screen of the ADPKD genes by DHPLC
Rossetti, S., Chauveau, D., Walker, D., Saggar-Malik, A., Winearls, C. G., Torres, V. E., & Harris, P. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00326.x · Cited by 170
Self-citationAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variation
Abkevich, V., Zharkikh, A., Deffenbaugh, A. M., Frank, D., Chen, Y., Shattuck, D., Skolnick, M. H., Gutin, A., & Tavtigian, S. V. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015867 · Cited by 168
Torrá, R., Bádenas, C., Darnell, A., Nicolau, C., Volpini, V., Revert, L., & Estivill, X. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7102142 · Cited by 153
Chenevix‐Trench, G., Healey, S. C., Lakhani, S. R., Waring, P., Cummings, M. C., Brinkworth, R. I., Deffenbaugh, A. M., Burbidge, L. A., Pruss, D., Judkins, T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3546 · Cited by 150
A latrophilin/CL-1-like GPS domain in polycystin-1
Ponting, C. P., Hofmann, K., & Bork, P. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80379-0 · Cited by 147
The PLAT domain: a new piece in the PKD1 puzzle
Bateman, A. G., & Sandford, R. N. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80380-7 · Cited by 144
Comprehensive genomic analysis of PKHD1 mutations in ARPKD cohorts
Sharp, A., Messiaen, L. M., Page, G. P., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024489 · Cited by 124
A Spectrum of Mutations in the Second Gene for Autosomal Dominant Polycystic Kidney Disease (PKD2)
Veldhuisen, B., Saris, J. J., de Haij, S., Hayashi, T., Reynolds, D. M., Mochizuki, T., ELLES, R. G., Fossdal, R., Bogdanova, N., van Dijk, M. A., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/515497 · Cited by 105
Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome
King, K., Flinter, F. A., Nihalani, V., & Green, P. (2002) · Human Genetics · doi:10.1007/s00439-002-0830-3 · Cited by 104
Watnick, T. J., Piontek, K. B., Cordal, T. M., Weber, H., Gandolph, M. A., Qian, F., Lens, X. M., Neumann, H. P., & Germino, G. G. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1473 · Cited by 102
Gene conversion is a likely cause of mutation in PKD1
Watnick, T. J., Gandolph, M. A., Weber, H., Neumann, H. P., & Germino, G. G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1239 · Cited by 95
Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants
Pagenstecher, C., Wehner, M., Friedl, W., Rahner, N., Aretz, S., Friedrichs, N., Sengteller, M., Henn, W., Buettner, R., Propping, P., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-0107-8 · Cited by 94
Identification of two novel polycystic kidney disease-1-like genes in human and mouse genomes
Li, A., Tian, X., Sung, S.-W., & Somlo, S. (2003) · Genomics · doi:10.1016/s0888-7543(03)00048-x · Cited by 85
Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions
Leeuwen, I. S. L., Leonhard, W. N., Dauwerse, H. G., Baelde, H. J., van Oost, B. A., Breuning, M. H., & Peters, D. J. M. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201392 · Cited by 38
Large deletions in the polycystic kidney disease 1 (PKD1) gene
Ariyürek, Y., Leeuwen, I. S. L., Spruit, L., Ravine, D., Breuning, M. H., & Peters, D. J. M. (2003) · Human Mutation · doi:10.1002/humu.9208 · Cited by 30
Cited by
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationYao, Q., Wu, M., Zhou, J., Zhou, M., Chen, D., Fu, L., Bian, R., Xing, X., Sun, L., Hu, X., et al. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000474961 · Cited by 847
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationHarris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Self-citationUnified Criteria for Ultrasonographic Diagnosis of ADPKD
Pei, Y., Obaji, J., Dupuis, A., Paterson, A. D., Magistroni, R., Dicks, E., Parfrey, P., Cramer, B., Coto, E., Torra, R., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050507 · Cited by 762
Metadata
- Authors
- Rossetti, S., Consugar, M. B., Chapman, A. B., Torres, V. E., Guay-Woodford, L. M., Grantham, J. J., Bennett, W. M., Meyers, C. M., Walker, D. L., Bae, K., Zhang, Q. (., Thompson, P. A., Miller, J. P., & Harris, P. C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-07
- Volume
- 18
- Issue
- 7
- Pages
- 2143-2160
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2164628127
- Cited by
- 439
- References
- 50
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.